Published on
Last updated on
Cisema Webinar with CBBC: Opportunities and Regulatory Implications Associated with the Rise of China's Digital Economy in Healthcare
Cisema will jointly present a webinar session with the China-Britain Business Council on July 30 to provide an overview of the latest policies and market opportunities for digital healthcare in China.
The session will be interactive, and will go through many interesting topics:
- What are the key digital health trends in China?
- How does risk class classification for the NMPA (former CFDA) work?
- Are there any fast-track regulatory pathways?
- What are the latest updates regarding digital health regulations?
Date: July 30
Time: 09:30AM – 10:30AM
Price: Free of charge
Open for: CBBC members only
Our speakers:
Anna King
Business Consultant, Cisema
Hamish King
Director of Business Development, Cisema
Related News
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.